Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT03343834 · COMPLETED
Trial details
- NCT number
- NCT03343834
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2021-08-05
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.